Drug
Ralimetinib clinical trials
Also written LY2228820.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
5 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 2
Eli Lilly and Company (3) · Centre Jean Perrin (1) · Centre Francois Baclesse (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ralimetinib is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Study of LY2228820 in Participants With Advanced CancerCompletedPhase 1Eli Lilly and CompanyNCT01393990Written as LY2228820
- A Study LY2228820 for Recurrent Ovarian CancerCompletedPhase 1/2Eli Lilly and CompanyNCT01663857Written as LY2228820
- Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed GlioblastomaCompletedPhase 1/2Centre Jean PerrinNCT02364206Written as LY2228820
- A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic CancerCompletedPhase 1Eli Lilly and CompanyNCT02860780Written as ralimetinib
- A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE InhibitorsTerminatedPhase 2Centre Francois BaclesseNCT02322853Written as Ralimetinib (LY2228820 dimesylate)
Codes
What other systems call ralimetinib · ClinicalTrials.gg INT006272
- MeSH (NLM) C580958ralimetinibOne source NLM
- UNII (FDA) 73I34XW4HDRALIMETINIBConfirmed FDA, NLM, Wikidata
- Wikidata Q27088512ralimetinibConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C143046RalimetinibOne source FDA
- DrugBank DB11787One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C580958 | ralimetinib | One source NLM |
| UNII (FDA) | 73I34XW4HD | RALIMETINIB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27088512 | ralimetinib | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C143046 | Ralimetinib | One source FDA |
| DrugBank | DB11787 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.